These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 25768432)

  • 21. Use of triclabendazole for treatment of patients co-infected by Fasciola spp. and S. mansoni in Behera Governorate, Egypt.
    Barduagni P; Hassanein Y; Mohamed M; Wakeel AE; Sayed ME; Hallaj Z; Curtale F
    Parasitol Res; 2008 Mar; 102(4):631-3. PubMed ID: 18071750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthelmintic activity of the natural compound (+)-limonene epoxide against Schistosoma mansoni.
    Moraes Jd; Almeida AA; Brito MR; Marques TH; Lima TC; Sousa DP; Nakano E; Mendonça RZ; Freitas RM
    Planta Med; 2013 Mar; 79(3-4):253-8. PubMed ID: 23408270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on heterologous resistance between Schistosoma mansoni and Fasciola hepatica in inbred rats.
    Ford MJ; Taylor MG; McHugh SM; Wilson RA; Hughes DL
    Parasitology; 1987 Feb; 94 ( Pt 1)():55-67. PubMed ID: 3103048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Threat of Triclabendazole Resistance in Fasciola hepatica.
    Kelley JM; Elliott TP; Beddoe T; Anderson G; Skuce P; Spithill TW
    Trends Parasitol; 2016 Jun; 32(6):458-469. PubMed ID: 27049013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.
    Novobilský A; Amaya Solis N; Skarin M; Höglund J
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):141-147. PubMed ID: 27380550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
    Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole.
    Meaney M; Fairweather I; Brennan GP; Ramasamy P; Subramanian PB
    Parasitol Res; 2002 Apr; 88(4):315-25. PubMed ID: 11999018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How anthelmintics help us to understand helminths.
    Vanden Bossche H
    Parasitology; 1985 Apr; 90 ( Pt 4)():675-85. PubMed ID: 4011323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity.
    Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel and selective inactivators of Triosephosphate isomerase with anti-trematode activity.
    Ferraro F; Corvo I; Bergalli L; Ilarraz A; Cabrera M; Gil J; Susuki BM; Caffrey CR; Timson DJ; Robert X; Guillon C; Freire T; Álvarez G
    Sci Rep; 2020 Feb; 10(1):2587. PubMed ID: 32054976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of pre-exposure to Fasciola hepatica or Schistosoma mansoni on challenge infection with Fasciola hepatica.
    el-Azazy OM; Schillhorn Van Veen TW
    Vet Parasitol; 1985 Jan; 17(2):173-6. PubMed ID: 3992871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.
    McConville M; Brennan GP; McCoy M; Castillo R; Hernandez-Campos A; Ibarra F; Fairweather I
    Parasitology; 2006 Aug; 133(Pt 2):195-208. PubMed ID: 16650337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative activity of triclabendazole metabolites against the liver fluke, Fasciola hepatica.
    Halferty L; Brennan GP; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2009 Feb; 159(2):126-38. PubMed ID: 19027238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quorum sensing N-Acyl homoserine lactones are a new class of anti-schistosomal.
    Whiteland H; Crusco A; Bloemberg LW; Tibble-Howlings J; Forde-Thomas J; Coghlan A; Murphy PJ; Hoffmann KF
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008630. PubMed ID: 33075069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
    Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
    Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural observations on oral ingestion and trans-tegumental uptake of clorsulon by the liver fluke, Fasciola hepatica.
    Meaney M; Haughey S; Brennan GP; Fairweather I
    Parasitol Res; 2005 Feb; 95(3):201-12. PubMed ID: 15645289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.
    O'Neill JF; Johnston RC; Halferty L; Brennan GP; Keiser J; Fairweather I
    J Helminthol; 2009 Jun; 83(2):151-63. PubMed ID: 19368748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni.
    Manneck T; Haggenmüller Y; Keiser J
    Parasitology; 2010 Jan; 137(1):85-98. PubMed ID: 19814844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.